Elisa Bellini
About
In The Last Decade
Elisa Bellini
16 papers receiving 304 citations
Peers
Comparison fields: 5 of 58
- Molecular Biology 115
- Genetics 114
- Oncology 77
- Pulmonary and Respiratory Medicine 64
- Surgery 42
Countries citing papers authored by Elisa Bellini
This map shows the geographic impact of Elisa Bellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Bellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Bellini more than expected).
Fields of papers citing papers by Elisa Bellini
This network shows the impact of papers produced by Elisa Bellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Bellini. The network helps show where Elisa Bellini may publish in the future.
Co-authorship network of co-authors of Elisa Bellini
This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Bellini. A scholar is included among the top collaborators of Elisa Bellini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Bellini. Elisa Bellini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 28 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 24 | |
| 12 | 11 | |
| 13 | 0 | |
| 14 | 13 | |
| 15 | 25 | |
| 16 | 29 | |
| 17 | 74 | |
| 18 | 2 | |
| 19 | 60 | |
| 20 | Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients. | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.